commercial-intelligence
(5)
The Agency That Ate Its Own Org Chart
Inizio Evoke spent years collecting specialist agencies. Then it made the unusual admission that the collection had become the problem - and began turning a maze of names into one healthcare commercialization machine.
Malbek Wants to Fire the Spreadsheet Running Your Contract Department
The Princeton software company is betting that contracts should behave less like buried paperwork and more like operating data. Its best proof is wonderfully unglamorous: fewer legal touches, shorter cycles and no consultant army hiding behind the setup screen.
G LNK
G LNK is a New York-based healthcare commercial intelligence platform (Y Combinator W25) that helps pharma, biotech, and medtech teams find the right medical experts, benchmark fair-market compensation, and stay compliant. Its AI search sits on a searchable clinician database - 9.2M+ HCP profiles at last count - and automates the full lifecycle of engaging healthcare professionals, from identification and tiering to compliant payment and regulatory oversight across 150+ countries.
AcuityMD
AcuityMD is a Boston-based commercial intelligence platform built specifically for the medical device (MedTech) industry. It translates large volumes of healthcare claims and procedure data into intuitive workflows, AI-powered insights, and recommendations that help medical device sales and marketing teams find high-value physicians and care sites, size and segment markets, manage territories, and accelerate product adoption. Founded in 2019 by former MedTech and consulting operators, the company serves hundreds of device makers - including a majority of the largest MedTech firms - and raised an $80M Series C in 2026 at a near-$1B valuation.
Michael Monovoukas
Michael Monovoukas is the CEO and co-founder of AcuityMD, a Boston-based commercial intelligence platform for the medical device industry. Founded in 2019, AcuityMD gives medtech sales teams a shared view of physicians, procedures, and referral networks. In April 2026 the company raised an $80M Series C led by StepStone Group, pushing its valuation near $1B and total funding past $160M.